-
Something wrong with this record ?
Lysate of Parabacteroides distasonis prevents severe forms of experimental autoimmune encephalomyelitis by modulating the priming of T cell response
Z. Jiraskova Zakostelska, M. Kraus, S. Coufal, P. Prochazkova, Z. Slavickova, T. Thon, T. Hrncir, J. Kreisinger, K. Kostovcikova, P. Kleinova, J. Lizrova Preiningerova, M. Pavelcova, V. Ticha, I. Kovarova, E. Kubala Havrdova, H....
Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2010
Free Medical Journals
from 2010
PubMed Central
from 2010
Europe PubMed Central
from 2010
Open Access Digital Library
from 2010-01-01
Open Access Digital Library
from 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2010
- MeSH
- Bacteroidetes immunology MeSH
- Encephalomyelitis, Autoimmune, Experimental * immunology prevention & control MeSH
- Mice, Inbred C57BL * MeSH
- Mice MeSH
- Gastrointestinal Microbiome * immunology MeSH
- Intestinal Mucosa immunology microbiology metabolism MeSH
- T-Lymphocytes immunology metabolism MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
The gut microbiota influences the reactivity of the immune system, and Parabacteroides distasonis has emerged as an anti-inflammatory commensal. Here, we investigated whether its lysate could prevent severe forms of neuroinflammation in experimental autoimmune encephalomyelitis (EAE) in mice and how this preventive strategy affects the gut microbiota and immune response. Lysate of anaerobically cultured P. distasonis (Pd lysate) was orally administered to C57BL/6 mice in four weekly doses. One week later, EAE was induced and disease severity was assessed three weeks after induction. Fecal microbiota changes in both vehicle- and Pd lysate-treated animals was analyzed by 16S V3-V4 amplicon sequencing and qPCR, antimicrobial peptide expression in the intestinal mucosa was measured by qPCR, and immune cell composition in the mesenteric and inguinal lymph nodes was measured by multicolor flow cytometry. Pd lysate significantly delayed the development of EAE and reduced its severity when administered prior to disease induction. EAE induction was the main factor in altering the gut microbiota, decreasing the abundance of lactobacilli and segmented filamentous bacteria. Pd lysate significantly increased the intestinal abundance of the genera Anaerostipes, Parabacteroides and Prevotella, and altered the expression of antimicrobial peptides in the intestinal mucosa. It significantly increased the frequency of regulatory T cells, induced an anti-inflammatory milieu in mesenteric lymph nodes, and reduced the activation of T cells at the priming site. Pd lysate prevents severe forms of EAE by triggering a T regulatory response and modulating T cell priming to autoantigens. Pd lysate could thus be a future modulator of neuroinflammation that increases the resistance to multiple sclerosis.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003019
- 003
- CZ-PrNML
- 005
- 20250206104017.0
- 007
- ta
- 008
- 250121e20241216sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fimmu.2024.1475126 $2 doi
- 035 __
- $a (PubMed)39737164
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Jiraskova Zakostelska, Zuzana $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
- 245 10
- $a Lysate of Parabacteroides distasonis prevents severe forms of experimental autoimmune encephalomyelitis by modulating the priming of T cell response / $c Z. Jiraskova Zakostelska, M. Kraus, S. Coufal, P. Prochazkova, Z. Slavickova, T. Thon, T. Hrncir, J. Kreisinger, K. Kostovcikova, P. Kleinova, J. Lizrova Preiningerova, M. Pavelcova, V. Ticha, I. Kovarova, E. Kubala Havrdova, H. Tlaskalova-Hogenova, M. Kverka
- 520 9_
- $a The gut microbiota influences the reactivity of the immune system, and Parabacteroides distasonis has emerged as an anti-inflammatory commensal. Here, we investigated whether its lysate could prevent severe forms of neuroinflammation in experimental autoimmune encephalomyelitis (EAE) in mice and how this preventive strategy affects the gut microbiota and immune response. Lysate of anaerobically cultured P. distasonis (Pd lysate) was orally administered to C57BL/6 mice in four weekly doses. One week later, EAE was induced and disease severity was assessed three weeks after induction. Fecal microbiota changes in both vehicle- and Pd lysate-treated animals was analyzed by 16S V3-V4 amplicon sequencing and qPCR, antimicrobial peptide expression in the intestinal mucosa was measured by qPCR, and immune cell composition in the mesenteric and inguinal lymph nodes was measured by multicolor flow cytometry. Pd lysate significantly delayed the development of EAE and reduced its severity when administered prior to disease induction. EAE induction was the main factor in altering the gut microbiota, decreasing the abundance of lactobacilli and segmented filamentous bacteria. Pd lysate significantly increased the intestinal abundance of the genera Anaerostipes, Parabacteroides and Prevotella, and altered the expression of antimicrobial peptides in the intestinal mucosa. It significantly increased the frequency of regulatory T cells, induced an anti-inflammatory milieu in mesenteric lymph nodes, and reduced the activation of T cells at the priming site. Pd lysate prevents severe forms of EAE by triggering a T regulatory response and modulating T cell priming to autoantigens. Pd lysate could thus be a future modulator of neuroinflammation that increases the resistance to multiple sclerosis.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a encefalomyelitida autoimunitní experimentální $x imunologie $x prevence a kontrola $7 D004681
- 650 12
- $a střevní mikroflóra $x imunologie $7 D000069196
- 650 _2
- $a myši $7 D051379
- 650 12
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a Bacteroidetes $x imunologie $7 D041963
- 650 _2
- $a T-lymfocyty $x imunologie $x metabolismus $7 D013601
- 650 _2
- $a střevní sliznice $x imunologie $x mikrobiologie $x metabolismus $7 D007413
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kraus, Michal $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Coufal, Stepan $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Prochazkova, Petra $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Slavickova, Zaneta $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Thon, Tomas $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Hrncir, Tomas $u Laboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, Novy Hradek, Czechia
- 700 1_
- $a Kreisinger, Jakub $u Laboratory of Animal Evolutionary Biology, Department of Zoology, Faculty of Science, Charles University, Prague, Czechia
- 700 1_
- $a Kostovcikova, Klara $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Kleinova, Pavlina $u Department of Neurology and Centre of Clinical Neuroscience, First Medical Faculty, Charles University and General Medical Hospital in Prague, Prague, Czechia
- 700 1_
- $a Lizrova Preiningerova, Jana $u Department of Neurology and Centre of Clinical Neuroscience, First Medical Faculty, Charles University and General Medical Hospital in Prague, Prague, Czechia
- 700 1_
- $a Pavelcova, Miluse $u Department of Neurology and Centre of Clinical Neuroscience, First Medical Faculty, Charles University and General Medical Hospital in Prague, Prague, Czechia
- 700 1_
- $a Ticha, Veronika $u Department of Neurology and Centre of Clinical Neuroscience, First Medical Faculty, Charles University and General Medical Hospital in Prague, Prague, Czechia
- 700 1_
- $a Kovarova, Ivana $u Department of Neurology and Centre of Clinical Neuroscience, First Medical Faculty, Charles University and General Medical Hospital in Prague, Prague, Czechia
- 700 1_
- $a Kubala Havrdova, Eva $u Department of Neurology and Centre of Clinical Neuroscience, First Medical Faculty, Charles University and General Medical Hospital in Prague, Prague, Czechia
- 700 1_
- $a Tlaskalova-Hogenova, Helena $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Kverka, Miloslav $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
- 773 0_
- $w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 15 (20241216), s. 1475126
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39737164 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104013 $b ABA008
- 999 __
- $a ok $b bmc $g 2263045 $s 1239026
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 15 $c - $d 1475126 $e 20241216 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
- LZP __
- $a Pubmed-20250121